Illumina

Yahoo Finance • 2 days ago

Jim Cramer on Illumina (ILMN): ‘A Challenged Company’ That He Doesn’t Prefer

We recently published a list of Jim Cramer’s Latest Lightning Round: 7 Stocks in Focus. In this article, we are going to take a look at where Illumina, Inc. (NASDAQ:ILMN) stands against other stocks that Jim Cramer discusses in latest ligh... Full story

Yahoo Finance • 8 days ago

Illumina lowers outlook due to China sales ban, to cut $100 million in costs

(Reuters) -Illumina on Monday lowered its annual forecast and said it plans to cut $100 million in spending after China announced a ban on imports of its genetic sequencing instruments. The company said it now expects 2025 adjusted profit... Full story

Yahoo Finance • 8 days ago

Illumina addresses recent developments in China

Announces Fiscal Year 2025 Non-GAAP Diluted EPS of Approximately $4.50 SAN DIEGO, March 10, 2025 /PRNewswire/ -- Illumina, Inc. (Nasdaq: ILMN) ("Illumina" or the "company") today responded to the March 4, 2025 notice from the China Minist... Full story

Yahoo Finance • last month

Trickle-down effect of NIH funding battle worries healthcare analysts and medical experts

Federal health research funding has faced a tumultuous four days after the Trump administration announced cuts Friday to a certain type of funding for the National Institutes of Health (NIH) — causing concern in the drug research world tha... Full story

Yahoo Finance • last month

Why Illumina (ILMN) Stock Is Falling Today

Why Illumina (ILMN) Stock Is Falling Today What Happened? Shares of genomics company Illumina (NASDAQ:ILMN) fell 8.6% in the morning session after the company reported fourth-quarter results and provided full-year revenue guidance, which... Full story

Yahoo Finance • 5 months ago

Charles Dadswell to step down as General Counsel, Illumina initiates search for successor

SAN DIEGO, Oct. 3, 2024 /PRNewswire/ -- Illumina, Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, announced that after 11 years of service, Charles "Chuck" Dadswell will step down as General Counsel and... Full story

Yahoo Finance • 6 months ago

Shareholders in Illumina (NASDAQ:ILMN) are in the red if they invested three years ago

While not a mind-blowing move, it is good to see that the Illumina, Inc. (NASDAQ:ILMN) share price has gained 23% in the last three months. But that doesn't change the fact that the returns over the last three years have been disappointing... Full story

Yahoo Finance • 6 months ago

Illumina and LGC Biosearch Technologies join forces to drive genomic innovation in agriculture

Amid rising agricultural complexity and the push for sustainability, genomics is at the forefront of innovation in breeding practices. SINGAPORE, Sept. 19, 2024 /PRNewswire/ -- Illumina (NASDAQ: ILMN) a global leader in genomics, and LGC... Full story

Yahoo Finance • 7 months ago

FDA approves Illumina cancer biomarker test with two companion diagnostics to rapidly match patients to targeted therapies

TruSight Oncology Comprehensive is the first US FDA-approved, distributable comprehensive genomic profiling IVD kit with pan-cancer companion diagnostic claims The 500+ gene biomarker test advances access to localized precision oncology f... Full story

Yahoo Finance • 7 months ago

Illumina, Inc. (ILMN): Is This Cheap Robotic Stock a Good Buy Right Now?

We recently compiled a list of the 10 Cheap Robotics Stocks To Buy.In this article, we are going to take a look at where Illumina, Inc. (NASDAQ:ILMN) stands against the other cheap robotic stocks. The progress of Western civilization is b... Full story

Yahoo Finance • 11 months ago

Evidence Supports Sequencing As First-Line Rare Disease Diagnostic

The Medical Genome Initiative presents a paper in an effort to expand patient access to sequencing Originally published on Illumina News Center NORTHAMPTON, MA / ACCESSWIRE / April 17, 2024 / A recent literature review, published in the... Full story

Yahoo Finance • 12 months ago

14 Best Medical Device Stocks To Buy Now

In this article, we will discuss the 14 Best Medical Device Stocks To Buy Now. You can skip our detailed analysis of the Medical Device Industry and go directly to the 5 Best Medical Device Stocks To Buy Now. The healthcare sector relies... Full story

Yahoo Finance • last year

10 Biggest Stocks Targeted By Activist Investors Right Now

In this article, we're going to take a look at 10 biggest stocks targeted by activist investors right now. You can skip ahead and take a look at more stocks that made our list by jumping straight to the top 5 biggest stocks targeted by act... Full story

Yahoo Finance • last year

Do You Believe in the Growth Prospects of Illumina (ILMN)?

RiverPark Advisors, an investment advisory firm and sponsor of the RiverPark family of mutual funds, released its “RiverPark Large Growth Fund” fourth quarter 2023 investor letter. A copy of the same can be downloaded here. The Russell 100... Full story

Yahoo Finance • last year

Illumina Inc CEO Jacob Thaysen Acquires 7,330 Shares

On February 22, 2024, Jacob Thaysen, CEO of Illumina Inc (NASDAQ:ILMN), made a significant insider purchase, acquiring 7,330 shares of the company's stock, as reported in a recent SEC Filing. This transaction has caught the attention of ma... Full story

Yahoo Finance • last year

15 Best Shareholder Activism Law Firms

In this article, we discuss the 15 Best Shareholder Activism Law Firms. If you would like to discuss our detailed discussion and analysis of the shareholder activism space as of 2024, you can skip it and go directly to 5 Best Shareholder A... Full story

Yahoo Finance • last year

Illumina Reports Financial Results for Fourth Quarter and Fiscal Year 2023

Revenue of $1.12 billion for Q4 2023, up 4% from Q4 2022 (up 4% on a constant currency basis) Revenue of $4.50 billion for fiscal year 2023, down 2% from fiscal year 2022 (flat on a constant currency basis) Shipped 79 NovaSeq X instruments... Full story

Yahoo Finance • last year

Here’s How the New AI Algorithm Helps Illumina (ILMN)

Ensemble Capital Management, an investment management company, released its fourth quarter 2023 investor letter. A copy of the same can be downloaded here. The fund saw exceptionally excellent absolute and relative performance in the fourt... Full story

Yahoo Finance • last year

Illumina To Webcast Upcoming Investor Conference

SAN DIEGO, Dec. 19, 2023 /PRNewswire/ -- Illumina, Inc. (NASDAQ: ILMN) today announced that its executives will be speaking at the following investor conference: 42nd Annual J.P. Morgan Healthcare Conference on January 9, 2024 Presentati... Full story

Yahoo Finance • last year

Heard on the Street: Illumina Nears the End of Its Painful Grail Saga

Grail’s screening test, called Galleri, could one day help save countless lives by catching cancer in the bloodstream early. After losing in court [against the Federal Trade Commission](https://www.wsj.com/health/healthcare/court-sides-wit... Full story